Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Alternative names
insulin human (humulin) (2 trials)
Key: Generex Biotechnology Corp. (5) Acquired (4)
ae37 + gm-csf vaccine (1 trial)
ae37 peptide vaccine (1 trial)
cyclophosphamide (cytoxan) (3 trials)
gm-csf vaccine (1 trial)
gp2 peptide (1 trial)
imiquimod (aldara) (1 trial)
pembrolizumab (keytruda) (1 trial)
sargramostim (leukine) (3 trials)
tapa-pulsed dendritic cells (4 trials)
Breast Neoplasms (Phase 2)
Diabetes Mellitus (Phase 3)
Triple Negative Breast Neoplasms (Phase 2)
Trials (8 total)
Trial APIs (10 total)